All Outputs (143)

Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis (2023)
Journal Article
Hussain, B., Malik, H., Mamas, M. A., Desai, R., Aggarwal, V., Kumar, G., …Paul, T. K. (2023). Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis. Journal of the Society for Cardiovascular Angiography & Interventions, Article 101267. https://doi.org/10.1016/j.jscai.2023.101267

Background Infiltrative diseases (ID), including amyloidosis, sarcoidosis, and hemochromatosis comprise a wide spectrum of disorders characterized by abnormal cellular infiltration in multiple organs, including th... Read More about Clinical Outcomes of Percutaneous Coronary Intervention in Amyloidosis, Sarcoidosis, and Hemochromatosis.

Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials. (2023)
Journal Article
Rivera, F. B., Cha, S. W., Aparece, J. P., Jariyatamkitti, S., & Mamas, M. (in press). Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials. Journal of Cardiovascular Pharmacology, 83(3), 265-270. https://doi.org/10.1097/FJC.0000000000001533

The role of colchicine for the prevention of postoperative atrial fibrillation (POAF) following cardiothoracic surgery is not well-established. We aimed to evaluate its potential in preventing POAF using data from randomized controlled trials (RCTs).... Read More about Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials..

RWD1 Capacity-Enhancing Innovation (CEI) and the Treatment of Severe Symptomatic Aortic Stenosis (sSAS) in England (2023)
Journal Article
Sarmah, A., Busca, R., & Mamas, M. (2023). RWD1 Capacity-Enhancing Innovation (CEI) and the Treatment of Severe Symptomatic Aortic Stenosis (sSAS) in England. Value in Health, 26(12), Article S504. https://doi.org/10.1016/j.jval.2023.09.2719

Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019 (2023)
Journal Article
Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre‐Finn, C., Morris, C., …Kontopantelis, E. (in press). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019. Cancer, https://doi.org/10.1002/cncr.35152

Background Anticoagulation of patients with atrial fibrillation (AF) and cancer is challenging because of their high risk for stroke and bleeding. Little is known of the variations of oral anticoagulant (OAC) prescribing in patients with AF with and... Read More about Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019.

Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective (2023)
Journal Article
Sharp, A. S. P., Kinnaird, T., Curzen, N., Ayyub, R., Alfonso, J. E., Mamas, M. A., & Bavière, H. V. (in press). Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective. European Heart Journal - Quality of Care and Clinical Outcomes, https://doi.org/10.1093/ehjqcco/qcad073

Background Use of intravascular ultrasound (IVUS) during percutaneous coronary intervention (PCI) is associated with improved clinical outcomes over angiography alone. Despite this, the adoption of IVUS in clinical practice remains low. Aims To... Read More about Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: A UK perspective.

European Society of Cardiology Core Curriculum for Cardio-Oncology. (2023)
Journal Article
López-Fernández, T., Farmakis, D., Ameri, P., Asteggiano, R., de Azambuja, E., Aznar, M., …Rosano, G. M. C. (in press). European Society of Cardiology Core Curriculum for Cardio-Oncology. European Journal of Heart Failure, 10.1002/ejhf.3102. https://doi.org/10.1002/ejhf.3102

Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant d... Read More about European Society of Cardiology Core Curriculum for Cardio-Oncology..

COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature. (2023)
Journal Article
Jaiswal, V., Mukherjee, D., Peng Ang, S., Kainth, T., Naz, S., Babu Shrestha, A., …Siller-Matula, J. M. (2023). COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature. IJC Heart & Vasculature, 49, 101280. https://doi.org/10.1016/j.ijcha.2023.101280

Background Myocarditis secondary to Coronavirus Disease 2019 (COVID-19) vaccination has been reported in the literature. Objective This study aimed to characterize the reported cases of myocarditis after COVID-19 vaccination based on age, gender... Read More about COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature..

Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer. (2023)
Journal Article
Kobo, O., Abramov, D., Fiuza, M., Chew, N. W. S., Ng, C. H., Parwani, P., …Mamas, M. A. (in press). Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer. Journal of the American Heart Association, 12(23), Article e030942. https://doi.org/10.1161/JAHA.123.030942

Although individuals with cancer experience high rates of cardiovascular morbidity, there are limited data on the potential differences in cardiovascular health (CVH) metrics between individuals with and without cancer. The National Health and Nutrit... Read More about Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer..

Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study. (2023)
Journal Article
Pana, T. A., Mamas, M. A., Wareham, N. J., Khaw, K., Dawson, D. K., & Myint, P. K. (in press). Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study. European Journal of Preventive Cardiology, Article zwad283. https://doi.org/10.1093/eurjpc/zwad283

Better understanding of sex differences in cardiovascular disease (CVD) is essential in tailoring appropriate preventative strategies. Using a large population-based study with follow-up >25 years, we aimed to determine sex-specific lifetime risks of... Read More about Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study..

Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis (2023)
Journal Article
Yong, J. H., Mai, A. S., Matetić, A., Elbadawi, A., Elgendy, I. Y., Lopez-Fernandez, T., & Mamas, M. A. (2024). Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis. The American Journal of Cardiology, 212, 80-102. https://doi.org/10.1016/j.amjcard.2023.11.039

Patients with haematological malignancies (HM) are at risk of future cardiovascular (CV) events. We therefore conducted a systematic review and meta-analysis to quantify their risk of future CV events. We searched Medline and Embase databases from in... Read More about Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis.

Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study (2023)
Journal Article
Marshall, M., Mason, K. J., Edwards, J. J., Mamas, M. A., Bailey, J., Heron, N., …Jordan, K. P. (2023). Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study. Rheumatology Advances in Practice, 8(1), Article rkad104. https://doi.org/10.1093/rap/rkad104

Objective Musculoskeletal pain is a common risk factor for co-morbid conditions and might increase the risk of poor outcomes. The objective was to determine whether patients with pre-existing musculoskeletal pain have an increased risk for mortality... Read More about Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study.

Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study). (2023)
Journal Article
Gupta, A., Shrivastava, A., Chhikara, S., Mamas, M. A., Vijayvergiya, R., Swamy, A., …Singh, C. (in press). Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study). Catheterization and Cardiovascular Interventions, 103(1), 51-60. https://doi.org/10.1002/ccd.30915

Among the two stent strategies, contemporary evidence favors double kissing crush technique (DKC) for complex unprotected distal left main bifurcation (UdLMB) lesions. However one of the major challenges to these lesions is side branch (SB) restenosi... Read More about Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study)..

Trends in Cardiovascular Mortality Among Individuals with Alzheimer's Disease in the United States, 1999-2020 (2023)
Journal Article
Ranganathan, S., Abramov, D., Chew, N. W., Mallen, C., Marshall, M., Kobo, O., & Mamas, M. A. (2024). Trends in Cardiovascular Mortality Among Individuals with Alzheimer's Disease in the United States, 1999-2020. The American Journal of Cardiology, 211, Article 326-333. https://doi.org/10.1016/j.amjcard.2023.11.044

This study aimed to compare the trends in cardiovascular diseases (CVD)-related mortality in patients with Alzheimer's Disease (AD) and in the general population aged 65 and above. Data from the CDC WONDER Multiple Cause of Death da... Read More about Trends in Cardiovascular Mortality Among Individuals with Alzheimer's Disease in the United States, 1999-2020.

Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis (2023)
Journal Article
Khan, S. U., Agarwal, S., Arshad, H. B., Akbar, U. A., Mamas, M. A., Arora, S., …Shah, A. R. (in press). Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ, 383, e077848. https://doi.org/10.1136/bmj-2023-077848

Objective: To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk. Design: Systematic review and... Read More about Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.

Sex specific lifetime risk of incident cardiovascular events. Results from a large British population-based cohort study (2023)
Journal Article
Pana, T. A., Mamas, M. A., Wareham, N. J., Khaw, K. T., Dawson, D. K., & Myint, P. K. (2023). Sex specific lifetime risk of incident cardiovascular events. Results from a large British population-based cohort study. European Heart Journal, 44(Supplement_2), https://doi.org/10.1093/eurheartj/ehad655.2375

Background There are marked sex differences in cardiovascular (CV) disease, most characteristically with men having a higher risk of coronary heart disease and myocardial infarction (MI). The sex differences in the absolute lifetime risk of CV diseas... Read More about Sex specific lifetime risk of incident cardiovascular events. Results from a large British population-based cohort study.

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study (2023)
Journal Article
Shanmuganathan, J., Kragholm, K. H., Schou, M., Torp-Pedersen, C., Ostergaard Poulsen, L., Pareek, M., …Freeman, P. (2023). Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study. European Heart Journal, 44(Supplement_2), https://doi.org/10.1093/eurheartj/ehad655.1208

Background Myocardial infarction is a cardiac adverse event associated with fluoropyrimidines such as 5-fluorouracil and its orally available prodrug capecitabine. There are limited data on the incidence, risk, and prognosis of capecitabine associate... Read More about Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study.

Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among patients with cardiogenic shock (2023)
Journal Article
Mohamed, M., Kinnaird, T., Rab, T., Zaman, S., Banerjee, A., Sirker, A., …Mamas, M. (2023). Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among patients with cardiogenic shock. European Heart Journal, 44(Supplement_2), https://doi.org/10.1093/eurheartj/ehad655.2111

Background Intracoronary imaging (ICI), including intravascular ultrasound (IVUS) or optical coherence tomography (OCT), is known to correlate with a reduction in rates of cardiac death after percutaneous coronary intervention (PCI), driven by lower... Read More about Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among patients with cardiogenic shock.

Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among complex patient groups (2023)
Journal Article
Mohamed, M., Kinnaird, T., Wijeysundera, H. C., Johnson, T. W., Zaman, S., Moledina, S., & Mamas, M. (2023). Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among complex patient groups. European Heart Journal, 44(Supplement_2), https://doi.org/10.1093/eurheartj/ehad655.2112

Background Intracoronary imaging (ICI) has been previously shown to improve survival and clinical outcomes after percutaneous coronary intervention (PCI). However, whether this prognostic benefit is sustained across different indications/patient grou... Read More about Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among complex patient groups.

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study (2023)
Journal Article
Shanmuganathan, J., Schou, M., Haider Butt, J., Torp-Pedersen, C., Ostergaard Poulsen, L., Pareek, M., …Kragholm, K. H. (2023). Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study. European Heart Journal, 44(Supplement_2), https://doi.org/10.1093/eurheartj/ehad655.2699

Background Use of oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) with focus on sunitinib and pazopanib approved for treatment of patients with renal cell carcinoma (RCC) may be associated with cardiovascula... Read More about Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study.

Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study (2023)
Journal Article
Moledina, S., Weight, N., Dafaalla, M., Chen, D., Rashid, M., Mohamed, M., …Mamas, M. (2023). Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study. European Heart Journal, 44(Supplement_2), Article ehad655.3027. https://doi.org/10.1093/eurheartj/ehad655.3027

Background Contemporary studies have demonstrated that in non-ST-segment elevation myocardial infarction (NSTEMI), processes of care vary significantly according to biological sex. Little is known regarding variation in practice between geographical... Read More about Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study.